Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Meredith

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Radiology|August 1, 1991
Three-port perineal sparing techniqueS A Spencer, P N Pareek, I Brezovich, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiationM N Saleh, K P Raisch, M A Stackhouse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1991
Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibodyR F Meredith, A F LoBuglio, W E Plott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49R F Meredith, E E Partridge, R D Alvarez, et al.
Gynecologic Oncology|April 1, 1997
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II studyR D Alvarez, E E Partridge, M B Khazaeli, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerF Robert, M P Ezekiel, S A Spencer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancersJ A Bonner, K P Raisch, H Q Trummell, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Radiology|August 1, 1991
Three-port perineal sparing techniqueS A Spencer, P N Pareek, I Brezovich, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiationM N Saleh, K P Raisch, M A Stackhouse, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1991
Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibodyR F Meredith, A F LoBuglio, W E Plott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49R F Meredith, E E Partridge, R D Alvarez, et al.
Gynecologic Oncology|April 1, 1997
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II studyR D Alvarez, E E Partridge, M B Khazaeli, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerF Robert, M P Ezekiel, S A Spencer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2000
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancersJ A Bonner, K P Raisch, H Q Trummell, et al.
Pageof 6